Literature DB >> 8200474

Cell-type-specific nuclear translocation of fibroblast growth factor-2 isoforms during chicken kidney and limb morphogenesis.

R Dono1, R Zeller.   

Abstract

Analysis of the fibroblast growth factor-2 (FGF-2 or bFGF) proteins during chicken embryonic pattern formation and organogenesis revealed that three isoforms (18.5, 20.0, and 21.5 kDa) were synthesized by alternative translation initiation from one coding region. A highly specific antiserum was raised and used for studying the temporal and spatial distribution of the FGF-2 isoforms during chicken embryogenesis. The distribution of FGF-2 proteins during limb pattern formation has been unraveled. Their presence in both ectodermal and mesenchymal cells is consistent with an involvement in regulating the balance of growth and differentiation. High levels of FGF-2 proteins were furthermore detected in all epithelial cells of the developing kidney from the pronephric stage onward. The proteins were in general predominantly cytoplasmic, but a specific subpopulation of limb mesenchymal cells and kidney epithelial cells (podocytes) showed a striking nuclear localization. Nuclear translocation of the FGF-2 proteins occurred in differentiating podocytes of meso- and metanephric glomeruli and was maintained in adult kidneys. These results, in contrast to previous in vitro studies, revealed that nuclear accumulation of FGF-2 proteins is restricted to few specific cells during embryogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200474     DOI: 10.1006/dbio.1994.1151

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  16 in total

1.  Nuclear activities of basic fibroblast growth factor: potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals.

Authors:  M Arese; Y Chen; R Z Florkiewicz; A Gualandris; B Shen; D B Rifkin
Journal:  Mol Biol Cell       Date:  1999-05       Impact factor: 4.138

Review 2.  Signal transduction in podocytes--spotlight on receptor tyrosine kinases.

Authors:  Jochen Reiser; Sanja Sever; Christian Faul
Journal:  Nat Rev Nephrol       Date:  2014-01-07       Impact factor: 28.314

Review 3.  Ectoderm-mesoderm crosstalk in the embryonic limb: The role of fibroblast growth factor signaling.

Authors:  Francesca V Mariani; Marian Fernandez-Teran; Maria A Ros
Journal:  Dev Dyn       Date:  2017-02-06       Impact factor: 3.780

4.  The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia-reperfusion injury.

Authors:  Siyun Liao; Janet R Bodmer; Mohamad Azhar; Gilbert Newman; J Douglas Coffin; Thomas Doetschman; Jo El J Schultz
Journal:  J Mol Cell Cardiol       Date:  2010-01-29       Impact factor: 5.000

5.  Cell-cycle dependent anti-FGF-2 staining of chicken cardiac myocytes: movement from chromosomal to cleavage furrow- and midbody-associated sites.

Authors:  L Liu; J Dai; R R Fandrich; E Kardami
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

6.  Apoptosis in the chick wing bud and the permanence of FGF-2 rescue.

Authors:  J K Noveroske; J A MacCabe
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-02       Impact factor: 2.416

7.  Fibroblast growth factor 2 can replace ectodermal signaling for feather development.

Authors:  H Song; Y Wang; P F Goetinck
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

8.  Notochord repression of endodermal Sonic hedgehog permits pancreas development.

Authors:  M Hebrok; S K Kim; D A Melton
Journal:  Genes Dev       Date:  1998-06-01       Impact factor: 11.361

9.  Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice.

Authors:  R Dono; G Texido; R Dussel; H Ehmke; R Zeller
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

Review 10.  Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease.

Authors:  Siyun Liao; Janet Bodmer; Daniel Pietras; Mohamad Azhar; Tom Doetschman; Jo El J Schultz
Journal:  Dev Dyn       Date:  2009-02       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.